Tweet Content
“Hey PRESTO!” – Early identification of psoriatic arthritis
The past decade has seen the management of psoriatic arthritis (PsA) transform, with our rich therapeutic armamentarium truly revolutionising patient outcomes.
https://t.co/FJNX3mGCoy https://t.co/Whd8QKwmkU
Links
Effect of voclosporin in class V lupus nephritis Dr. Yusof ( @Yuz6Yusof) discusses abstract 0355 presented at #ACR22.
Tweet Content
Effect of voclosporin in class V lupus nephritis
Dr. Yusof ( @Yuz6Yusof) discusses abstract 0355 presented at #ACR22. Abstract 0355: Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study
https://t.co/v716QGx73g https://t.co/ANTOEDAAHt
Links
The CONSUL Trial: Ankylosing Spondylitis Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract 0546 presented at #ACR22.
Tweet Content
The CONSUL Trial: Ankylosing Spondylitis
Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract 0546 presented at #ACR22.
https://t.co/DXTn3XfEzC https://t.co/pbORtBsRm2
Links
JAK vs TNF inhibitor Infections in RA Dr. David Liew ( @drdavidliew) discusses abstract 0302 at #ACR22 Convergence. A
Tweet Content
JAK vs TNF inhibitor Infections in RA
Dr. David Liew ( @drdavidliew) discusses abstract 0302 at #ACR22 Convergence. Abstract 0302: Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
https://t.co/GsOsWtuT7v https://t.co/GloKEcB75L
Links
Does BASDAI work for women? In Abstract 0406 S. Maguire et al sought to understand if BASDAI and BASFI captured diseas
Tweet Content
Does BASDAI work for women?
In Abstract 0406 S. Maguire et al sought to understand if BASDAI and BASFI captured disease activity and quality of life in female axSpA patients.
Read more from Dr. Rachel Tate ( @uptoTate ) #ACR22
https://t.co/yWzdRMPgpp https://t.co/YrMsAYbAWN
Links